3rd Quarter - Report

HART HEALTH STRATEGIES for RTI BIOLOGICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA issues

LobbyistCovered position, as disclosed
SHANA CHRISTRUP Senator Mike Enzi
MATTHEW DUCKWORTH —
JUDITH GORSUCH Senator Jon Kyl
EMILY GRAHAM —
VICKI HART Senator Bob Dole; Senator Trent Lott
TIMOTHY YEHL Senator Frank Lautenberg, Congressman Frank Pallone

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.